STOCKMARKETLOOP MARKET SIGNAL$MDGLMadrigal PharmaceuticalsOpen ticker analysis →
Madrigal Pharmaceuticals received a fresh analyst action dated 2026-09-24.
What changed for $MDGL?
Fresh rating and price-target changes can alter expectations and near-term positioning.
| New rating | BUY |
|---|---|
| Prior rating | BUY |
| New target | $704.00 |
| Prior target | $567.00 |
| Firm | Goldman Sachs |
LOADING $MDGL LIVE MARKET DATA
What does this $MDGL signal not prove?
An analyst opinion is not a guarantee, and target prices can be revised without warning.
